You are here:Home-Chemical Inhibitors & Agonists-Ras-Raf-MAPK-ERK Pathway-MEKK (MAP3K)-KIN001-266
KIN001-266

Chemical Structure : KIN001-266

CAS No.: 915363-56-3

KIN001-266 (Tpl2 inhibitor 34, MAP3K8-IN-34)

Catalog No.: PC-45794Not For Human Use, Lab Use Only.

Tpl2-IN-34 is a potent, selective Tpl2 (cot/MAP3K8) inhibitor with IC50 of 1.6 nM.

Packing Price Stock Quantity
10 mg $198 In stock
25 mg $358 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

KIN001-266 (Tpl2-IN-34) is a potent, selective Tpl2 (cot/MAP3K8) inhibitor with IC50 of 1.6 nM.
Tpl2-IN-34 dispalys 6875-fold selectivity over EGFR. P38, Src, CAMKII, MK2, PKA, and PKC (IC50>10 uM).
Tpl2-IN-34 inhibits LPS-induced TNF-α production in whole blood with IC50 of 0.3 uM.
Tpl2-IN-34 shows good efficacy in inhibiting TNF-alpha production in a LPS-stimulated rat inflammation model; orally active.

Physicochemical Properties

M.Wt 539.4347
Formula C26H25Cl2FN8
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

3-Quinolinecarbonitrile, 8-chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-[[[1-(1-ethyl-4-piperidinyl)-1H-1,2,3-triazol-4-yl]methyl]amino]-

References

1. Wu J, et al. Bioorg Med Chem Lett. 2009 Jul 1;19(13):3485-8.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: